In a report released today, Matt McGinley from Needham maintained a Buy rating on Curaleaf Holdings (CURLF), with a price target of $5.50. The company’s shares closed last Monday at $3.85, close to its 52-week low of $2.54.
According to TipRanks.com, McGinley is ranked #3615 out of 6165 analysts.
Curaleaf Holdings has an analyst consensus of Strong Buy, with a price target consensus of $8.81, implying a 178.8% upside from current levels. In a report issued on March 18, Stifel Nicolaus also maintained a Buy rating on the stock with a C$22.00 price target.
See today’s analyst top recommended stocks >>
Based on Curaleaf Holdings’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $61.82 million and GAAP net loss of $6.84 million. In comparison, last year the company earned revenue of $21.37 million and had a GAAP net loss of $33.67 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.
Read More on CURLF:
